Search

Jan 13
SF Healthcare Week: Affinity Asset Advisors' Head of Research Patrick Nosker shares his take on Monday's conference news, and discusses some of his fund's top holdings
He talks about todays M&A heavy news and the market reaction to it, and comments on Xenon, Madrigal, Nurix, and Wave.

Jan 8, 2024
SF Healthcare Week: A buy side perspective of biotech with Affinity's Patrick Nosker
Patrick Nosker gives his take on today's conference news and highlights the science behind some of his firm's top holdings.